BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 38011007)

  • 21. Transcriptome analysis reveals the link between lncRNA-mRNA co-expression network and tumor immune microenvironment and overall survival in head and neck squamous cell carcinoma.
    Zhong Z; Hong M; Chen X; Xi Y; Xu Y; Kong D; Deng J; Li Y; Hu R; Sun C; Liang J
    BMC Med Genomics; 2020 Mar; 13(1):57. PubMed ID: 32228580
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of the immune cell function landscape in head and neck squamous carcinoma to assist in prognosis prediction and immunotherapy.
    Wang W; Zhang Z; Li W; Wei D; Xu J; Qian Y; Cao S; Lei D
    Aging (Albany NY); 2023 Nov; 15(21):12588-12617. PubMed ID: 37955651
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Constructing heterogeneous single-cell landscape and identifying microenvironment molecular characteristics of primary and lymphatic metastatic head and neck squamous cell carcinoma.
    Zhang J; Liu Y; Xia L; Zhen J; Gao J; Atsushi T
    Comput Biol Med; 2023 Oct; 165():107459. PubMed ID: 37713790
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mast cell marker gene signature in head and neck squamous cell carcinoma.
    Cai Z; Tang B; Chen L; Lei W
    BMC Cancer; 2022 May; 22(1):577. PubMed ID: 35610596
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of a prediction model for radiotherapy response among patients with head and neck squamous cell carcinoma based on the tumor immune microenvironment and hypoxia signature.
    Zhu GL; Yang KB; Xu C; Feng RJ; Li WF; Ma J
    Cancer Med; 2022 Dec; 11(23):4673-4687. PubMed ID: 35505641
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic value of novel immune-related genomic biomarkers identified in head and neck squamous cell carcinoma.
    Yao Y; Yan Z; Lian S; Wei L; Zhou C; Feng D; Zhang Y; Yang J; Li M; Chen Y
    J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32719094
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An ion-channel-gene-based prediction model for head and neck squamous cell carcinoma: Prognostic assessment and treatment guidance.
    Han Y; Shi Y; Chen B; Wang J; Liu Y; Sheng S; Fu Z; Shen C; Wang X; Yin S; Li H
    Front Immunol; 2022; 13():961695. PubMed ID: 36389709
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Screening the key genes of prognostic value in the microenvironment for head and neck squamous cell carcinoma.
    Meng D; Liu T; Ma F; Wang M
    Medicine (Baltimore); 2021 Jan; 100(4):e24184. PubMed ID: 33530209
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Metabolism-Related Gene Prognostic Index Bridging Metabolic Signatures and Antitumor Immune Cycling in Head and Neck Squamous Cell Carcinoma.
    Du K; Zou J; Wang B; Liu C; Khan M; Xie T; Huang X; Shen P; Tian Y; Yuan Y
    Front Immunol; 2022; 13():857934. PubMed ID: 35844514
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HtrA3: a promising prognostic biomarker and therapeutic target for head and neck squamous cell carcinoma.
    Chen Y; Yang J; Jin H; Wen W; Xu Y; Zhang X; Wang Y
    PeerJ; 2023; 11():e16237. PubMed ID: 37842043
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Down-regulation of HLA-B-associated transcript 3 impairs the tumoricidal effect of natural killer cells through promoting the T cell immunoglobulin and mucin domain-containing-3 signaling in a mouse head and neck squamous cell carcinoma model.
    Yang J; Xiang J; Zhu M; Zhao Y; Zhou L; Hu B; Wang C
    Immunobiology; 2022 Jan; 227(1):152127. PubMed ID: 34968777
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stemness-related lncRNAs signature as a biologic prognostic model for head and neck squamous cell carcinoma.
    Xu Z; Zhang M; Guo Z; Chen L; Yang X; Li X; Liang Q; Tang Y; Liu J
    Apoptosis; 2023 Jun; 28(5-6):860-880. PubMed ID: 36997733
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Circadian Regulator-Mediated Molecular Subtypes Depict the Features of Tumor Microenvironment and Indicate Prognosis in Head and Neck Squamous Cell Carcinoma.
    Aye L; Wang Z; Chen F; Xiong Y; Zhou J; Wu F; Hu L; Wang D
    J Immunol Res; 2023; 2023():9946911. PubMed ID: 37342762
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel metabolic-related gene signature for predicting clinical prognosis and immune microenvironment in head and neck squamous cell carcinoma.
    Cao Y; Dai Z; Xie G; Liu G; Guo L; Zhang J
    Exp Cell Res; 2023 Jul; 428(2):113628. PubMed ID: 37149080
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification and verification of aging-related lncRNAs for prognosis prediction and immune microenvironment in patients with head and neck squamous carcinoma.
    Gao Q; Shi Y; Sun Y; Zhou S; Liu Z; Sun X; DI X
    Oncol Res; 2023; 31(1):35-61. PubMed ID: 37303739
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic value of immune-related genes and immune cell infiltration analysis in the tumor microenvironment of head and neck squamous cell carcinoma.
    Wang Z; Yuan H; Huang J; Hu D; Qin X; Sun C; Chen G; Wang B
    Head Neck; 2021 Jan; 43(1):182-197. PubMed ID: 33009692
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The prognostic impact of the immune signature in head and neck squamous cell carcinoma.
    Baysal H; Siozopoulou V; Zaryouh H; Hermans C; Lau HW; Lambrechts H; Fransen E; De Pauw I; Jacobs J; Peeters M; Pauwels P; Vermorken JB; Smits E; Lardon F; De Waele J; Wouters A
    Front Immunol; 2022; 13():1001161. PubMed ID: 36268020
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Construction of a necroptosis-related lncRNA signature to predict the prognosis and immune microenvironment of head and neck squamous cell carcinoma.
    Huang J; Xu Z; Teh BM; Zhou C; Yuan Z; Shi Y; Shen Y
    J Clin Lab Anal; 2022 Jun; 36(6):e24480. PubMed ID: 35522142
    [TBL] [Abstract][Full Text] [Related]  

  • 39. FAM3 Family as Prognostic Factors for Head and Neck Squamous Cell Carcinoma.
    Liao C; Wang Q; An J; Wang H; Xiao L; Long Q; Zhao H; Liu J; Guan X
    Comb Chem High Throughput Screen; 2023; 26(3):539-558. PubMed ID: 35538834
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Integrated multi-omics analysis identifies CD73 as a prognostic biomarker and immunotherapy response predictor in head and neck squamous cell carcinoma.
    Shen A; Ye Y; Chen F; Xu Y; Zhang Z; Zhao Q; Zeng ZL
    Front Immunol; 2022; 13():969034. PubMed ID: 36466881
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.